# Shorla Oncology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shorla-oncology

- Industry: Pharmaceuticals
- Headquarters: Clonmel, Ireland
- Website: www.shorlaoncology.com/
- Total disclosed funding: $46M
- Latest round: Series B (Oct 4, 2023)
- Investors on record: 7

## About

Founded in 2018 and based in Clonmel, Ireland, Shorla Pharma Limited doing business as Shorla Oncology, is a specialty pharmaceutical company that focuses on the research and development of oncology drugs for women and children suffering from pediatric cancer.

## Funding rounds

- Series B, Oct 4, 2023, $35M — Seroba, Kurma Partners, Enterprise Ireland
- Series A, Dec 17, 2021, $2M — Seroba, Ontario Inc., Enterprise Ireland, Kellysan Enterprises Limited, Vevan Unlimited Company, Coolbally Investments Limited
- Series A, Mar 27, 2020, $8.9M — Seroba, Enterprise Ireland, Ontario Inc., Kellysan Enterprises Limited, Vevan Unlimited Company, Coolbally Investments Limited

## Investors

- Seroba (https://capitalatlas.ai/funds/seroba) — Series A, Series B
- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Series A, Series B
- Ontario Inc. — Series A
- Kellysan Enterprises Limited (https://capitalatlas.ai/funds/kellysan-enterprises-limited) — Series A
- Vevan Unlimited Company — Series A
- Coolbally Investments Limited — Series A
- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Series B